MENU

Carb counting: could there be a better way?
Published on October 4, 2016

The current gold standard for calculating mealtime insulin for people with type 1 diabetes (T1D) is carbohydrate counting. ‘Carb counting’ uses the carb to insulin ratio determines the amount of insulin that is needed to cover the amount of carbohydrate that is going to be eaten. But what about the rest of the meal? Recent research and clinical observations […]

Share
Data to help break down glucose control barriers
Published on September 13, 2016

With just a third of young people falling within the target range of <7.5%, Australasia’s unique data registry highlights the need to reduce barriers to achieve better glucose control in young Australians living with type 1 diabetes (T1D). The Australasian Diabetes Data Network (ADDN), funded by the JDRF Type 1 Diabetes Clinical Research Network (T1DCRN) and […]

Share
New Report: Clinical research is accelerating patient impact
Published on August 30, 2016

The Type 1 Diabetes Clinical Research Network (T1DCRN) has made a significant announcement this week with the release of a major report on the deployment of the $35 million investment by the Australian Government. The report also gives new insight to how Australians will soon have unprecedented opportunities to participate in research through clinical trials. […]

Share

Preliminary research released today revealed findings on common genetic and environmental risk factors between two autoimmune diseases, type 1 diabetes (T1D) and multiple sclerosis (MS). Even though MS and T1D have very few clinical similarities, they co-occur more often than one would expect  by chance. This suggests that they share risk factors. Known common environmental […]

Share
An day in the life of Artie, the artificial pancreas
Published on August 9, 2016

Jeramie has just completed a JDRF-funded artificial pancreas (AP) trial over 12 weeks at the University of Virginia, one of the very first to be completed in an out-of-hospital setting. He’s also a JDRF staff member from the USA’s Kentucky & Southern Indiana Chapter. Jeramie blogged on his experience with the AP he nicknamed ‘Artie’ during the […]

Share
Next step in homegrown encapsulation research
Published on July 25, 2016

A team from the University of Technology Sydney (UTS) led by Professor Ann Simpson has recently received a US patent for a human cell line known as Melligen cells. Melligen cells are genetically engineered to produce, store and release insulin on demand in response to blood glucose levels, essentially replacing the insulin-producing function of the […]

Share
More than one way to close the loop
Published on June 23, 2016

The incredible progress in closed-loop technology that JDRF has fostered by funding and collaborating with academic institutions, research organisations and industry is poised to deliver an array of artificial pancreas (AP) options to the T1D community. By partnering enthusiastically with academia and industry, JDRF first seeded, then cultivated, a thriving network of experts dedicated to […]

Share
Wanted: cutting-edge research ideas
Published on June 9, 2016

The Australian Type 1 Diabetes Clinical Research Network’s (T1DCRN) Innovation Award is now open for applications. The Request for Applications (RFA) Innovation Award is to fund and advance promising innovation that, if successful, would improve the lives of people with type 1 diabetes.  JDRF and the T1DCRN are seeking innovative proposals describing cutting-edge innovation falling […]

Share
Link between early infections and type 1 diabetes 
Published on May 27, 2016

New JDRF-funded research published in the May issue of JAMA (The Journal of the American Medical Association) details evidence of a link between infections in early life and later development of type 1 diabetes (T1D). It has long been thought that there could be a link between common viral infections and the development of T1D. […]

Share